Condition
Cardiac Autonomic Neuropathy
Total Trials
6
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Unknown2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07684768Completed
IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL
NCT07613372Not ApplicableActive Not RecruitingPrimary
Evaluation of Cardiac Autonomic Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus
NCT05620927Unknown
Hypoglycemia Awareness Study in Diabetes Type 1
NCT05299918Completed
Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
NCT03931759Not ApplicableUnknown
The Effect of Intra-abdominal Pressure
NCT02056366Phase 4Completed
The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy
Showing all 6 trials